A rapidly increasing body of evidence supports involvement of the fibroblast growth factor 23 (FGF23)-klotho-vitamin D axis in the pathogenesis of cardiovascular disease in CKD patients [2]. This evidence concerns the gene KL and chronic kidney disease.